Patents by Inventor Jun-Hyoung Lee

Jun-Hyoung Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8242242
    Abstract: The present invention relates to an artificial transcription factor which can artificially regulate gene expression of an E. coli, wherein the transcription factor comprising zinc finger proteins and transcription factors of prokaryote, and to be engineered E. coli using the same. Specifically, the artificial transcription factors comprising zinc finger domains and transcription factors in E. coli as effector domains are prepared and said artificial transcription library is introduced to E. coli to effectively and artificially regulate gene expression regardless of an activity of endogenous transcription factors in the E. coli and to induce E. coli having various desired phenotypes. Thus, only E. coli having the desired phenotypes useful for industries can be selected and used.
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: August 14, 2012
    Assignee: Korea Advanced Institute of Science and Technology
    Inventors: Sun-Chang Kim, Ju-Young Lee, Bong-Hyun Sung, Jun-Hyoung Lee, Sang-Hee Lee, Kui-Hyeon Kang
  • Publication number: 20100136663
    Abstract: The present invention relates to an artificial transcription factor which can artificially regulate gene expression of an E. coli, wherein the transcription factor comprising zinc finger proteins and transcription factors of prokaryote, and to be engineered E. coli using the same. Specifically, the artificial transcription factors in E. coli as effector domains are prepared and said artificial transcription library is introduced to E. coli to effectively and artificially regulate gene expression regardless of an activity of endogenous transcription factors in the E. coli and to induce E. coli having various desired phenotypes. Thus, only E. coli having the desired phenotypes useful for industries can be selected and used.
    Type: Application
    Filed: December 15, 2006
    Publication date: June 3, 2010
    Applicant: Korea Advanced Institute of Science and Technology
    Inventors: Sun-Chang KIM, Ju-Young Lee, Bong-Hyun Sung, Jun-Hyoung Lee, Sang-Hee Lee, Kui-Hyeon Kang
  • Publication number: 20070287180
    Abstract: The present invention relates to Escherichia coli variants that have increased antibiotics susceptibility, diffusion efficiency, and transformation efficiency. The variants can minimize the problems caused by biofilm formation such as increased resistance to antibiotics, decreased solute diffusion efficiency, and lowered transformation efficiency. According to the present invention, when selecting genetically-modified E. coli variants, not only a lesser amount of antibiotics is required when selecting desirable variants, but also the reduction of selection efficiency caused by biofilm formation by strains other than the variants to be selected, thus decreasing exhibiting resistance to antibiotics, can be avoided. Additionally, in the process of materials production, the amount of secreted products could be increased due to the increased solute diffusion efficiency. Furthermore, the increased transformation efficiency makes the mass production of useful materials easier.
    Type: Application
    Filed: September 1, 2005
    Publication date: December 13, 2007
    Inventors: Sun-Chang Kim, Choong-Hoon Lee, Bo-Ram Lim, Bong-Hyun Sung, Byung-Jo Yu, Won-Sik Lee, Jun-Hyoung Lee, Sang-Hee Lee